April 2023
1. FACCHIN A, Benyoub N, Elie V, Magreault S, et al
   Limited Sampling Strategies to Predict Ganciclovir Exposure after Valganciclovir Administration and to Reduce Monitoring Constraints in Renal Transplant Children.
   Antimicrob Agents Chemother. 2023;67:e0159722.
   

   >> Share

   
   March 2023
2. SELBY PR, Heffernan AJ, Yeung D, Warner MS, et al
   Population Pharmacokinetics of Ganciclovir in Allogeneic Hematopoietic Stem Cell Transplant Patients.
   Antimicrob Agents Chemother. 2023;67:e0155022.
   

   >> Share

   
   February 2023
3. COJUTTI PG, Heffernan AJ, Tangden T, Della Siega P, et al
   Population Pharmacokinetic and Pharmacodynamic Analysis of Valganciclovir for Optimizing Preemptive Therapy of Cytomegalovirus Infections in Kidney Transplant Recipients.
   Antimicrob Agents Chemother. 2023 Feb 23:e0166522. doi: 10.1128/aac.01665.
   

   >> Share

   
   September 2022
4. HALPERN-COHEN V, Blumberg EA
   New Perspectives on Antimicrobial Agents: Maribavir.
   Antimicrob Agents Chemother. 2022;66:e0240521.
   

   >> Share

   
   August 2022
5. ROYSTON L, Masouridi-Levrat S, Gotta V, Royston E, et al
   Therapeutic Drug Monitoring of Orally Administered Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
   Antimicrob Agents Chemother. 2022;66:e0065722.
   

   >> Share

   
   June 2021
6. ZARROUK K, Zhu X, Pham VD, Goyette N, et al
   Impact of Amino Acid Substitutions in Region II and Helix K of Herpes Simplex Virus 1 and Human Cytomegalovirus DNA Polymerases on Resistance to Foscarnet.
   Antimicrob Agents Chemother. 2021;65:e0039021.
   

   >> Share

   
   February 2021
7. NGUYEN T, Oualha M, Briand C, Bendavid M, et al
   Population Pharmacokinetics of Intravenous Ganciclovir and Oral Valganciclovir in a Pediatric Population To Optimize Dosing Regimens.
   Antimicrob Agents Chemother. 2021;65.
   

   >> Share

   
   December 2020
8. SU H, Ye X, Freed DC, Li L, et al
   A potent bispecific neutralizing antibody targeting glycoprotein B and the gH/gL/pUL128/130/131 complex of human cytomegalovirus.
   Antimicrob Agents Chemother. 2020 Dec 23. pii: AAC.02422.
   

   >> Share

   
   October 2020
9. HAMILTON ST, Marschall M, Rawlinson WD
   Investigational antiviral therapy models for the prevention and treatment of congenital cytomegalovirus infection during pregnancy.
   Antimicrob Agents Chemother. 2020 Oct 19. pii: AAC.01627.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share